Vijaya Diagnostic Center, the largest integrated diagnostic chain in South India in terms of operating income, has repaired the ribbon price of Rs 522-531 per equity stock for its public offer. This is the 39th IPO this year.
Offer for offers will start from September 1 and will be closed on 3. September, if any, it will open for a day on August 31.
This offer is entirely an offer for sale 3,56,88,064 equity shares by promoters, and Investors of Kedaara Capital and Karakoram. The company plans to collect Rs 1,895.03 Crore via IPO, on a higher price ribbon.
Offers for sale consisted of sales of 50.98,296 shares of equity by the promoter of Dr S Surendranath Reddy, 2.94.87.290 Equity shares by Karakoram investors, and 11.02.478 Equity shares by Investor Kedaara Capital Alternative Investment Fund – Kedaara Capital 1.
This problem includes a 1.5 lakh equity stock reservation for its employees. Companies can share these shares with discounts to final problems prices. This offer will be a minimum of 35 percent of the company’s post-competitive equity stock capital.
Investors can bid a minimum of 28 equity shares and in multiples of 28 equity shares. Retail investors can bid for most of the shares of Rs 14,868 for one lot, and the maximum investment is Rs 1,93,284 shares worth 13 lots.
Half of the size of the offer is reserved for eligible institutional buyers, up to 35 percent for retail investors and the remaining 15 percent for non-institutional investors.
Vijaya Diagnostic Center is one of the fastest growing diagnostic chains by income for the Fiscal Year 2020. It offers a comprehensive circuit of around 740 routines and 870 special pathological tests and around 220 basic and 320 advanced radiological tests that cover various specialties and disciplines, in June 2021.
It has a broad operational network, which consists of 81 diagnostic centers and 11 reference laboratories in 13 cities and cities in the state of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata on the 2021.
The company was founded and promoted by Dr. Surendranath Reddy, chairman of the executive, holding 37.38 percent of shares in the company. It is also supported by Marquee Karakoram investors, and Capital Kedaara’s alternative investment funds – Kedaara Capital AIF 1.
The alternative investment fund of Kedaara Capital has 1.44 percent of the shares and Karakoram held 38.56 percent of shares in diagnostic chain operators.